Full text is available at the source.
Abstract
A small molecule inhibitor designed to target mitochondrial flap endonuclease 1 reduces leakage of oxidized mitochondrial DNA fragments.
- Oxidized mitochondrial DNA fragments trigger inflammation that can harm cells and tissues.
- A novel delivery system using hyaluronic acid and selenium nanoparticles encapsulates the inhibitor to enhance targeting and efficiency.
- The inhibitor prevents the cleavage of oxidized mitochondrial DNA, which may reduce its leakage from damaged mitochondria.
- In a model of acute respiratory distress syndrome, the delivery system suppresses inflammatory signaling related to oxidized mitochondrial DNA.
- The approach may provide a therapeutic strategy for conditions driven by oxidized mitochondrial DNA inflammation.
Simplified